Biotech firm FDNA has partnered with research organisations to create the Genomics Collaborative, which will use FDNA's artificial intelligence and machine learning technologies. Online This virtual event will bring together industry experts to discuss the increasing pace of pharmaceutical innovation, the need to maintain data quality and integrity as new technologies are implemented and understand regulatory challenges to ensure compliance. The partnership is part of a wider effort by the biopharmaceutical company to develop new ways for scientists to collaborate on research. Researchers at Lausanne will investigate the relationship between bone structure and genomic data in patients with skeletal dysplasia disorders. The Bridge the Gap and All Things Kabuki projects will perform facial analyses to improve early diagnosis and treatments.
Biotech firm FDNA has partnered with research organisations to create the Genomics Collaborative, which will use FDNA's artificial intelligence and machine learning technologies. The partnership is part of a wider effort by the biopharmaceutical company to develop new ways for scientists to collaborate on research. Researchers at Lausanne will investigate the relationship between bone structure and genomic data in patients with skeletal dysplasia disorders. The Bridge the Gap and All Things Kabuki projects will perform facial analyses to improve early diagnosis and treatments.